Bifogade filer
PDF
Beskrivning
| Land | Norge |
|---|---|
| Lista | 12 |
| Sektor | Hälsovård |
| Industri | Bioteknik |
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NEW ZEALAND, SOUTH AFRICA, HONG KONG, SWITZERLAND, SINGAPORE, SOUTH KOREA, RUSSIA, BELARUS OR IN ANY OTHER JURISDICTION WHERE THE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR REQUIRE ADDITIONAL REGISTRATION OR OTHER MEASURES BEYOND THOSE REQUIRED BY SWEDISH OR NORWEGIAN LAW.
Oslo, Norway, June 3, 2025 - Genetic Analysis AS ("GA" or the "Company") hereby announces that today, the 3rd of June, 2025, is the first day of trading excluding subscription rights in the ongoing Subsequent Issue.
Reference is made to the stock exchange announcement published by Genetic Analysis AS on 5 May, 27 May 2025 and 2 June 2025 regarding a Subsequent Issue in the Company.
The owners of shares in Genetic Analysis AS per 2 June as registered in the share registry held by Euronext Securities Oslo will receive one (1) subscription right per share and consequently today is the first day where the shares are trading exclusive of such subscription rights.